Puylaert Kevin
- SEC CIK
- 0002119354
In the past year, 6 open-market sale filings worth $4.61K and no purchases.
Current role at each company
- SOPH SOPHiA GENETICS SAChief Sales Officeras of Jul 7, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $4.61K
- 6 filings
- Net
- −$4.61K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Puylaert Kevin as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 7, 2026 (view filing)4:03 PM ET | Jul 6 | 1 day | Puylaert KevinChief Sales Officer | SSale | −216 | $5.03 | −$1.09K | −0.1%147.9K after | 3 lots |
| May 20, 2026 (view filing) | May 19 | 1 day | Puylaert KevinChief Sales Officer | SSale | −33 | $4.54 | −$149.82 | 0.0%148.2K after | |
| Apr 21, 2026 (view filing) | Apr 20 | 1 day | Puylaert KevinChief Sales Officer | SSale | −33 | $5.08 | −$167.64 | 0.0%148.2K after | |
| Apr 8, 2026 (view filing) | Apr 6 | 2 days | Puylaert KevinChief Sales Officer | SSale | −624 | $4.86 | −$3.03K | −0.4%148.2K after | 3 lots |
| Apr 1, 2026 (view filing) | Mar 31 | 1 day | Puylaert KevinChief Sales Officer | SSale | −3 | $4.71 | −$14.13 | 0.0%92.4K after | |
| Mar 20, 2026 (view filing) | Mar 19 | 1 day | Puylaert KevinChief Sales Officer | SSale | −33 | $4.76 | −$157.08 | 0.0%92.4K after |